Reducing mortality, improving outcomes, and establishing equity for women with classical haematological disease: a Lancet Haematology Commission

Study limitation reported by the research below: “Level of evidence assigned as '3' is a conservative estimate for a Commission report; actual grading may vary by individual recommendation within the document.”